Asia-Pacific heart pump devices market is expected to reach USD 756.15 million by 2025 and is projected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of cardiac disease, rapid advancement in surgical technique in VAD implantation, increasing popularity of minimal invasive surgical procedures in cardiology, regulatory approval of heart pump devices are fuel the growth of heart pump devices market.

The key market players for Asia-Pacific heart pump devices market are listed below;

Abbott
Getinge AB
Teleflex Incorporated
Abiomed
Berlin Heart
BiVACOR Inc
Calon Cardio
CardiacAssist, Inc
Jarvik Heart, Inc.
Medtronic
ReliantHeart Inc.
SynCardia Systems, LLC
Terumo Corporation
Thoratec Corporation

The Asia-Pacific heart pump devices market is segmented into;
Products
Type
Therapy
End User
?
On the basis of product the Asia-Pacific heart pump devices market is segmented into ventricular assist devices, intra-aortic balloon pump, total artificial heart (TAH). In 2018, intra-aortic balloon pumps are expected to dominate the Asia-Pacific heart pump devices market with highest market shares. However, ventricular assist devices are expected to grow at the highest CAGR in the forecast period. Ventricular assist devices is further sub segmented into left ventricular assist devices, right ventricular assist device, a biventricular assist device (BiVAD), and percutaneous ventricular assist device.
On the basis of type the Asia-Pacific heart pump devices market is categorized into implantable heart pump devices and extracorporeal heart pump devices. In 2018, implantable heart pump devices are expected to dominate the Asia-Pacific heart pump devices market with the highest CAGR in the forecast period 2018 to 2025.
On the basis of therapy Asia-Pacific heart pump devices market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC) destination therapy and others. In 2018, bridge-to-transplant (BTT) are expected to dominate the Asia-Pacific heart pump devices market with the highest CAGR in the forecast period 2018 to 2025.
On the basis of end user the Asia-Pacific heart pump devices market is segmented into hospitals, ambulatory surgical centers, clinics and research institutes. In 2018, hospitals are expected to dominate the Asia-Pacific heart pump devices market with highest market shares and in the forecast period 2018 to 2025.

Based on geography, the market is segmented into;
Japan
China
India
South Korea
Australia
Singapore
Thailand
Malaysia
Indonesia
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific heart pump devices market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.